Comparative evaluation of IV ketorolac and IV paracetamol in laparoscopic surgeries: a systematic review and meta-analysis
Open Access
- 14 October 2026
- journal article
- review article
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (11) , 7399-7412
Abstract
Background: Effective postoperative pain control is essential for enhanced recovery after laparoscopic surgery. Intravenous ketorolac and paracetamol are widely used non-opioid agents in multimodal analgesia, but their relative efficacy and safety remain controversial. Methods: Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 guidelines, databases were searched through September 2025 for randomized and comparative studies of intravenous (IV) ketorolac versus IV paracetamol. Pooled effect estimates with 95% confidence intervals were calculated using RevMan 5.4. The primary outcome was postoperative visual analog scale (VAS) pain scores; secondary outcomes included the timing and use of rescue analgesia, hemodynamic parameters, and adverse events. Results: Eight studies encompassing 540 patients met inclusion criteria. IV ketorolac significantly reduced VAS scores at 2 hours (MD = −0.95; 95% CI: −1.17 to −0.74; P < 0.00001), 4 hours (MD = −0.99; 95% CI: −1.62 to −0.35; P = 0.002), and 8 hours (MD = −0.45; 95% CI: −0.78 to −0.13; P = 0.006) postoperatively compared with IV paracetamol. The time to first rescue analgesia was significantly longer with ketorolac (MD = 1.93; 95% CI: 1.26–2.61; P < 0.00001). Postoperative vomiting occurred less frequently with ketorolac, while other adverse events and hemodynamic parameters were comparable between the groups. Substantial statistical heterogeneity was present for some outcomes. Conclusion: Intravenous ketorolac provides better early postoperative analgesia and longer-lasting pain relief than intravenous paracetamol following laparoscopic surgery, without increased adverse events. Vomiting was also less frequent with ketorolac. Both agents showed acceptable short-term safety and may be used for multimodal, opioid-sparing analgesia guided by patient and procedural factors.This publication has 25 references indexed in Scilit:
- Efficacy and adverse effects of lower doses of ketorolac; a systematic review and meta-analysisPain Management, 2025
- Nonsteroidal anti-inflammatory drugs in the perioperative period: current controversies and concernsBritish Journal of Anaesthesia, 2024
- Risk‐of‐bias VISualization (robvis): An R package and Shiny web app for visualizing risk‐of‐bias assessmentsResearch Synthesis Methods, 2020
- Comparison of Intravenous Ketorolac at Three Single-Dose Regimens for Treating Acute Pain in the Emergency Department: A Randomized Controlled TrialAnnals of Emergency Medicine, 2017
- Does Ketorolac Have a Preemptive Analgesic Effect? A Randomized, Double-Blind, Control StudyJournal of Oral and Maxillofacial Surgery, 2013
- Multimodal analgesia for controlling acute postoperative painCurrent Opinion in Anaesthesiology, 2009
- Paracetamol (Acetaminophen): mechanisms of actionPediatric Anesthesia, 2008
- Efficacy and Safety of Single and Repeated Administration of 1 Gram Intravenous Acetaminophen Injection (Paracetamol) for Pain Management after Major Orthopedic SurgeryAnesthesiology, 2005
- Comparative effect of paracetamol, NSAIDs or their combination in postoperative pain management: a qualitative reviewBritish Journal of Anaesthesia, 2002
- Central effect of Ketorolac involving NMDA receptors activityBrain Research, 1998